A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease

Overview

Radcliffe Cardiology is delighted to announce that Transcatheter Interventions Online (TIO) will return on 9–12 April 2025.

Over five hugely successful years, TIO has established itself as a leading virtual event serving the educational needs of the global interventional cardiology community.

Under the guidance of Course Director, Prof Nicolas Van Mieghem (Erasmus MC, Rotterdam, NL), TIO brings together a faculty of international renown, case centres of excellence and a global audience of thousands of HCPs, for education that is both authoritative and enduring in support of superior patient outcomes.

With a mix of live cases, practical tips and tricks, insightful presentations and debate, this CME-accredited event will again be carefully curated to enhance knowledge, address practical challenges and explore innovative solutions in real-world settings.

Due to demand from our attendees, this year’s programme has been extended to four days. The first three days will maintain a global outlook, with faculty and case centres selected to represent and resonate with our truly international audience. The new fourth day will be TIO 2025 I US Focus – dedicated to the challenges of US-based practice.

With a reach that is truly global – in 2024, over 2,500 healthcare professionals from 155 countries joined for CME-accredited best-in-class education – TIO 2025 promises to be larger still.

Whatever your geographical location of practice, TIO 2025 is here to support your endeavour to achieve optimum outcomes in clinical practice.

Register now to join thousands of HCPs worldwide at TIO 2025.

Join the conversation - #TIOCongress2025

*Transcatheter Interventions Online 2025's programme will be submitted to the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 11 CME points, equating to 11 hours of effective education time. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Event starts in:

Share this event:

Programme

(Please note this programme is subject to change)

Day 1 - Structural Heart Disease

3:00 PM - 3:05 PM (CEST)

Day One Welcome

3:05 PM - 4:00 PM (CEST)

Session 1.1

Upstream TAVR Has Arrived, Should Guidelines Follow?

Chair: Nicolas Van Mieghem, Rotterdam, NL and Ole De Backer, Copenhagen, DK

Panel: Anita Asgar, Chicago, US; Sabine Bleiziffer, Bad Oeynhausen, DE; Thomas Modine, Bordeaux, FR; Giuseppe Tarantini, Padua, IT

  • Moderate AS - What’s Next After TAVR UNLOAD – Nicolas Van Mieghem, Rotterdam, NL

  • Asymptomatic Severe AS – A Home Run – Anita Asgar, Chicago, US

  • Pure Aortic Regurgitation – A Legitimate TAVR Target? – Thomas Modine, Bordeaux, FR

 



4:00 PM - 5:00 PM (CEST)

Session 1.2

Live Cases

Chair: Ole De Backer, Copenhagen, DK

Panel: Anita Asgar, Chicago, US; Sabine Bleiziffer, Bad Oeynhausen, DE; Thomas Modine, Bordeaux, FR; Giuseppe Tarantini, Padua, IT

  • Pure Aortic Regurgitation Case – Nicolas Van Mieghem, Erasmus MC, Rotterdam, NL

  • TAVR-in-TAVR Case – Holger Thiele and Mohamed Abdel-Wahab, Leipzig Heart Center, Leipzig, DE

 



6:00 PM - 7:00 PM (CEST)

Session 1.3

Atrioventricular Valves

Chair: Azeem Latib, New York, US

Panel: Anita Asgar, Chicago, US; Adam Greenbaum, Atlanta, US; David Hildick-Smith, Brighton, UK; Philipp Lurz, Mainz, DE; Thomas Modine, Bordeaux, FR

  • A Plea for Upstream Secondary MR Treatment – Philipp Lurz, Mainz, DE

  • The Importance of Complete Elimination of TR – Adam Greenbaum, Atlanta, US

  • How Strongly Do We Need to Recommend Transcatheter LAA Closure – David Hildick-Smith, Brighton, UK

 



7:00 PM - 7:55 PM (CEST)

Session 1.4

Live Cases

Chair: Azeem Latib, New York, US

Panel: Anita Asgar, Chicago, US; Adam Greenbaum, Atlanta, US; Thomas Modine, Bordeaux, FR

  • TTVR Case – Philipp Lurz, University Medical Center Mainz, Mainz, DE

  • LAA Case – David Hildick-Smith, Royal Sussex County Hospital, Brighton, UK

 



7:55 PM - 8:00 PM (CEST)

Day One Close


Day 2 - Complex PCI

2:00 PM - 2:05 PM (CEST)

Day Two Welcome

3:05 PM - 4:00 PM (CEST)

Session 2.1

Drug Coated Balloons

Chair: Margaret McEntegart, New York, US

Panel: Joost Daemen, Rotterdam, NL; Roxana Mehran, New York, US; Giuseppe Tarantini, Padua, IT

  • Overview of the DCB Market / What Is New in Coronary Devices – Margaret McEntegart, New York, US

  • The Undisputed Indications for DCB – Giuseppe Tarantini, Padua, IT

  • How to Interpret a Good DCB Result With Invasive Imaging – Joost Daemen, Rotterdam, NL

 



4:00 PM - 5:00 PM (CEST)

Session 2.2

Live Cases

Chair: Margaret McEntegart, New York, US

Panel: Joost Daemen, Rotterdam, NL; Roxana Mehran, New York, US; Giuseppe Tarantini, Padua, IT

  • Proximal LAD Imaging Guided – Holger Thiele and Mohamed Abdel-Wahab, Leipzig Heart Center, Leipzig, DE

  • LM Bifurcation DCB Case – David Hildick-Smith, Royal Sussex County Hospital, Brighton, UK

 



6:00 PM - 7:00 PM (CEST)

Session 2.3

Calcium Modification Revisited

Chair: Ajay Kirtane, New York, US

Panel: Azeem Latib, New York, US; Margaret McEntegart, New York, US; Valeria Paradies, Rotterdam, NL; Holger Thiele, Leipzig, DE

  • Latest Science on Atherectomy – Ajay Kirtane, New York, US

  • Updates on Coronary Lithotripsy – Azeem Latib, New York, US

  • Use More Invasive Imaging Guidance – Valeria Paradies, Rotterdam, NL



7:00 PM - 7:55 PM (CEST)

Session 2.4

Live Cases

Chair: Ajay Kirtane, New York, US

Panel: Azeem Latib, New York, US; Margaret McEntegart, New York, US; Valeria Paradies, Rotterdam, NL; Holger Thiele, Leipzig, DE

  • Atherectomy Case – Joost Daemen and Nicolas Van Mieghem, Erasmus MC, Rotterdam, NL

  • Lithotripsy Case – George Dangas and Annapoorna Kini, Mount Sinai, New York, US

 



7:55 PM - 8:00 PM (CEST)

Day Two Close


Day 3 - Debates & Controversies

3:05 PM - 4:00 PM (CEST)

Day Three Welcome

3:05 PM - 4:00 PM (CEST)

Session 3.1

Keynote & Debate

Chair: Ajay Kirtane, New York, US

Panel: Roxana Mehran, New York, US; Holger Thiele, Leipzig, DE; Nicolas Van Mieghem, Rotterdam, NL

Keynote: Mike Gibson, Boston, US

  • Iterative AI – Mike Gibson, Boston, US

  • ACC Highlights – Roxana Mehran, New York, US

 



4:00 PM - 5:00 PM (CEST)

Session 3.2

Live Cases

Chair: Ajay Kirtane, New York, US

Panel: Roxana Mehran, New York, US; Holger Thiele, Leipzig, DE; Nicolas Van Mieghem, Rotterdam, NL

  • TAVR in Bicuspid AS – Erasmus MC, Rotterdam, NL

  • Live Case

 



6:00 PM - 6:55 PM (CEST)

Session 3.3

Controversies

Chair: Nicolas Van Mieghem, Rotterdam, NL

Panel: Joost Daemen, Rotterdam, NL; Michaela Hell, Mainz, DE; Ajay Kirtane, New York, US; Holger Thiele, Leipzig, DE

  • Is Photon Counting CT a Game Changer? – Michaela Hell, Mainz, DE

  • Pulmonary Thrombectomy Deserves a Strong Recommendation inthe Guidelines – Holger Thiele, Leipzig, DE

  • How Valid Is Quality of Life as a Major Study Endpoint? – Joost Daemen, Rotterdam, NL

 



6:55 PM - 7:00 PM (CEST)

Day Three Close


Day 4 - US Focus

US Focus – Coronary Sessions

3:00 PM - 3:02 PM (CEST)

Day Four Welcome

3:02 PM - 3:30 PM (CEST)

Session 4.1

DCBs in Contemporary Practice

Chair: Ajay Kirtane, New York, US

Panel: Margaret McEntegart, New York, US; Azeem Latib, New York, US;

  • What Are DCBs and Why and How Do I Use Them?

  • Where Should DCBs Be Deployed?



3:30 PM - 4:00 PM (CEST)

Session 4.2

Renal Denervation – Time for Action?

Chair: Ajay Kirtane, New York, US

Panel: Eric Secemsky, Boston, US; Matheen Khuddus, Gainesville, US;

  • Which Patients Benefit From RDN?

  • How to Set Up a RDN Programme in 2025?



4:00 PM - 4:30 PM (CEST)

Session 4.3

Approaching Calcified Lesions in 2025

Chair: Ajay Kirtane, New York, US

Panel: Margaret McEntegart, New York, US; Kathleen Kearney, Seattle, US;

  • What’s Our Strategy?

  • What Role Does Imaging Play?



4:30 PM - 5:00 PM (CEST)

Session 4.4

Should Acute PE Intervention Be Performed Routinely by ICs?

Chair: Ajay Kirtane, New York, US

Panel: Sahil Parikh, New York, US; Sonal Pruthi, New York, US; Sanjum Sethi, New York, US; Eric Secemsky, Boston, US;

  • Should Acute PE Intervention Be Performed Routinely by ICs?

  • How to Set Up an Acute PE Program

 




US Focus – Structural Sessions

5:00 PM - 5:40 PM (CEST)

Session 4.5

Aortic Session

Chair: Azeem Latib, New York, US

Panel: Anita Asgar Chicago, US; Vinayak Bapat, New York, US; Susheel Kodali, New York, US; Nicolas Van Mieghem, Rotterdam, NL

  • TAVR in Younger Patients – Where Do We Stand?

  • Case-In-A-Box With Discussion – TAVR in TAVR / TAVR Explant

  • The Future

 



5:40 PM - 6:20 PM (CEST)

Session 4.6

Mitral Session

Chair: Azeem Latib, New York, US

Panel: Anita Asgar Chicago, US; Vinayak Bapat, New York, US; Neil Fam, Toronto, CA; Susheel Kodali, New York, US; Nicolas Van Mieghem, Rotterdam, NL

  • Contemporary Mitral Valve Intervention in 2025

  • Case-in-a-box With Discussion – Emerging Technology

  • The Future

 



6:20 PM - 7:00 PM (CEST)

Session 4.7

Tricuspid Session

Chair: Azeem Latib, New York, US

Panel: Anita Asgar Chicago, US; Vinayak Bapat, New York, US; Neil Fam, Toronto, CA; Susheel Kodali, New York, US; Nicolas Van Mieghem, Rotterdam, NL

  • Contemporary Tricuspid Valve Intervention in 2025

  • Case-in-a-box With Discussion – Emerging Technology

  • The Future

 




Course Leadership

Nicolas Van Mieghem

Nicolas Van Mieghem
Course Director
Thoraxcenter, Erasmus MC, Rotterdam, NL

more info

David Hildick-Smith

David Hildick-Smith
Course co-director
Sussex Cardiac Centre, Brighton and Sussex University Hospitals, Brighton, UK

more info

Roxana Mehran

Roxana Mehran
Course co-director
The Mount Sinai Hospital, New York, US

more info

Holger Thiele

Holger Thiele
Course co-director
Leipzig Heart Hospital, Leipzig, DE

more info

Ajay Kirtane

Ajay Kirtane
Course co-director
Columbia University Medical Center and New York-Presbyterian Hospital, New York, US

more info

Azeem Latib

Azeem Latib
Course co-director
Montefiore Medical Center, New York, US

more info

Faculty

Prof Mohamed Abdel-Wahab
Mohamed Abdel-Wahab

Leipzig Heart Center, Leipzig, DE

 Anita Asgar
Anita Asgar

Northwestern University, Chicago, US

 Sabine Bleiziffer
Sabine Bleiziffer

Heart and Diabetes Center NRW, Bad Oeynhausen, DE

Dr Joost Daemen
Joost Daemen

Thoraxcenter, Erasmus MC, Rotterdam, NL

 Ole De Backer
Ole De Backer

Rigshospitalet, Copenhagen, DK

 Michael Gibson
Michael Gibson

Harvard Medical School, Boston, US

 Adam Greenbaum
Adam Greenbaum

Emory University, Atlanta, US

Dr Philipp Lurz
Philipp Lurz

University Medical Center Mainz, Mainz, DE

Dr Margaret McEntegart
Margaret McEntegart

Columbia University Medical Center and New York-Presbyterian Hospital, New York, US

 Thomas Modine
Thomas Modine

Bordeaux University Hospital, Bordeaux, FR

 Valeria Paradies
Valeria Paradies

Maasstad Hospital, Rotterdam, NL

Prof Giuseppe Tarantini
Giuseppe Tarantini

University Hospital of Padova, Padova, IT

Learning Objectives

Day 1 - Structural Heart Disease

  • Assess TAVR's role in asymptomatic and moderate AS for future guidelines
  • Review new options for treating pure aortic regurgitation and mitral/tricuspid regurgitation
  • Explore emerging technologies in structural heart disease

Day 2 - Complex PCI

  • Discuss key uses and outcomes of Drug-Coated Balloons (DCBs) and new coronary devices
  • Review calcium modification techniques and the value of invasive imaging

Day 3 - Debates & Controversies

  • Explore how AI is shaping interventional cardiology
  • Debate pulmonary thrombectomy, MINOCA treatment, and ACC highlights

Day 4 - US Focus

  • Examine Drug-Coated Balloons (DCBs) in coronary procedures
  • Review advancements in Renal Denervation for hypertension
  • Understand sex differences in aortic valve disease

(Please note these learning objectives are subject to change)

Target Audience

  • Interventional Cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional Cardiology Nurses

Headline Educational Partner

If you’re interested in becoming an educational partner at TIO, please contact sales@radcliffe-group.com

Official Journal

Interventional Cardiology: Reviews, Research, Resources (ICR³) is an international, English language, peer-reviewed journal that publishes articles continuously on ICRjournal.com. It aims to assist time-pressured physicians to stay abreast of key advances and opinions in interventional cardiology.

Led by Editor-in-Chief Peter O'Kane, along with Deputy Editors and an editorial board of world-renowned physicians, the journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.

View the 2024 volume of ICR3

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com